Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Costantini

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Clinical and Experimental Rheumatology|December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumoniaGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL StudyPaolo Corradini, Chiara Agrati, Giovanni Apolone, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trialIrene J Higginson, Sarah T Brown, Adejoke O Oluyase, et al.
BMC Health Services Research|November 4, 2025
The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trialPeter May, Charles Normand, Adejoke O Oluyase, et al.
Journal of Translational Medicine|October 22, 2021
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
BMC Palliative Care|December 29, 2021
Effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with advanced cancer and their family caregivers (DIAdIC): study protocol for an international randomized controlled trialOrphé Matthys, Aline De Vleminck, Sigrid Dierickx, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Clinical and Experimental Rheumatology|December 4, 2020
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumoniaGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL StudyPaolo Corradini, Chiara Agrati, Giovanni Apolone, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trialIrene J Higginson, Sarah T Brown, Adejoke O Oluyase, et al.
BMC Health Services Research|November 4, 2025
The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trialPeter May, Charles Normand, Adejoke O Oluyase, et al.
Journal of Translational Medicine|October 22, 2021
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
Journal of Translational Medicine|October 22, 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
BMC Palliative Care|December 29, 2021
Effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with advanced cancer and their family caregivers (DIAdIC): study protocol for an international randomized controlled trialOrphé Matthys, Aline De Vleminck, Sigrid Dierickx, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Pageof 12